NASDAQ:UPB | Free Cash Flow | Upstream Bio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$47.85M
2025-12-31-$30.63M$54,000.00-$30.69M
2025-03-31-$41.17M
2024-12-31-$19.61M$185,000.00-$19.8M
2024-03-31-$17.56M
2023-12-31-$16.11M$0.00-$16.11M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$133.28M$165,000.00-$133.44M
2024-12-31-$59.17M$511,000.00-$59.68M
2023-12-31-$37.93M$144,000.00-$38.07M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.